nifedipine has been researched along with diazoxide in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (27.59) | 18.7374 |
1990's | 13 (22.41) | 18.2507 |
2000's | 14 (24.14) | 29.6817 |
2010's | 15 (25.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Topliss, JG; Yoshida, F | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Li, G; Mayr, GW; Pittet, D; Pralong, WF; Schlegel, W; Wollheim, CB | 1 |
Aizawa, T; Komatsu, M; Okada, N; Sato, Y; Yamada, T | 1 |
Bunchman, TE; Lynch, RE; Wood, EG | 1 |
Falke, LC; Gillis, KD; Misler, S; Pressel, DM | 1 |
Littler, WA; Smith, SA | 1 |
Naden, RP; Redman, CW | 1 |
Meese, RB; Ram, CV | 1 |
Anand, MP | 1 |
Ram, CV | 1 |
Song, YC | 1 |
Chapman, RW; Danko, G; Siegel, MI | 1 |
Brandt, D | 1 |
Acconcia, MC; Gaspardone, A; Pannarale, G; Valente, A | 1 |
Zsotér, TT | 1 |
Berkenboom, G; Sobolski, J; Stoupel, E | 1 |
Alberti, E; Camerini, F; Klugmann, S; Salvi, A | 1 |
Drobinski, G; Grosgogeat, Y; Komajda, M; Thomas, D | 1 |
Greer, MA; Greer, SE; Sato, N; Wang, X | 1 |
Kojima, I; Mine, T; Sekine, N; Shibata, H; Totsuka, Y; Yasuda, H | 1 |
de Jong, DJ; Huysmans, FT; Kloke, HJ; Koene, RA; van Hamersvelt, HW | 1 |
Carvajal, A; Dueñas, A; Fernández de la Gándara, F; Maroto, M; Nieto, A; Velasco, A | 1 |
Yamada, Y | 1 |
Bouskela, E; Conde, CM; Cyrino, FZ; Garcia, AA | 1 |
Araki, E; Kaneko, K; Kishikawa, H; Motoshima, H; Motoyoshi, S; Sakai, K; Shichiri, M; Shirakami, A; Shirotani, T; Yoshizato, K | 1 |
Ashraf, M; Wang, Y | 1 |
Ahrén, B; Karlsson, S | 1 |
An, J; Becker, GW; Churgay, LM; Gold, G; Hale, JE; Osborne, JJ; Shi, Y; Stramm, LE; Zhao, G | 1 |
Marik, PE; Varon, J | 1 |
Nagashima, K | 1 |
Budzko, D; Miki, T; Niki, I; Niwa, T; Senda, T; Yu, W | 1 |
Berggren, PO; Köhler, M; Larsson, O; Yang, SN; Zhang, F; Zhang, Q | 1 |
Bideci, A; Camurdan, MO; Cinaz, P; Demirel, F; Serdaroğlu, A | 1 |
Kwon, G; Liu, H; Marshall, CA; McDaniel, ML; Pappan, KL; Remedi, MS | 1 |
Aynsley-Green, A; Hussain, K; Stanley, CA | 1 |
Chang, Y; Li, GH; Lin, YF; Liu, Q; Mao, X; Misaki, N; Suga, S; Wakui, M; Wang, H; Wu, J | 1 |
Míguez, JM; Polakof, S; Soengas, JL | 1 |
Blasi, J; Escoriza, J; Montanya, E; Torrejón-Escribano, B | 1 |
Björklund, A; Catrina, SB; Grill, V; Hals, I; Ma, Z; Moruzzi, N; Oberholzer, J | 1 |
Akcurin, S; Bircan, I; Durmaz, E; Ellard, S; Flanagan, SE; Parlak, M | 1 |
Chen, K; Sun, P; Wang, H; Wang, T; Zhou, Y; Zhu, W | 1 |
Kim, MS; Kong, YH; Lee, DY | 1 |
Basak, D; Chatterjee, S; Flanagan, SE; Hussain, K; Khawash, P | 1 |
Hoshmandi, E; Karbalaei, N; Noorafshan, A | 1 |
Gilbert, C; Güemes, M; Hinchey, L; Hussain, K; Morgan, K; Shah, P; Silvera, S | 1 |
12 review(s) available for nifedipine and diazoxide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antihypertensive agents--the race for third place.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diazoxide; Felodipine; Humans; Hydralazine; Indoramin; Labetalol; Minoxidil; Nicardipine; Nifedipine; Vasodilator Agents; Verapamil | 1985 |
Antihypertensive drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Female; Fetus; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Nifedipine; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Regional Blood Flow; Uterus | 1985 |
Hypertensive cardiovascular emergencies.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Diazoxide; Diuretics; Eclampsia; Emergencies; Female; Humans; Hypertension; Hypertension, Malignant; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Pregnancy; Pulmonary Edema; Trimethaphan | 1985 |
Hypertension--drug management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Diazoxide; Humans; Hypertension; Indoramin; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Prazosin; Sympatholytics; Vasodilator Agents; Verapamil | 1982 |
Hypertensive crisis.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Diazoxide; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Phentolamine; Prazosin; Pregnancy; Pulmonary Edema; Trimethaphan | 1984 |
[Early pulmonary hypertension: current therapeutic prospectives].
Topics: Calcium Channel Blockers; Captopril; Diazoxide; Diltiazem; Humans; Hydralazine; Hypertension, Pulmonary; Isoproterenol; Nifedipine; Phentolamine; Time Factors | 1982 |
Calcium antagonists.
Topics: Action Potentials; Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Bronchial Spasm; Calcium; Diazoxide; Diltiazem; Hemodynamics; Humans; Hydralazine; Lanthanum; Muscle, Smooth; Myocardial Contraction; Nifedipine; Nitrites; Nitroprusside; Papillary Muscles; Verapamil | 1980 |
[Persistent hyperinsulinemic hypoglycemia of infancy (PHHI)].
Topics: Adenosine Triphosphate; Diazoxide; Glycosyltransferases; GTP-Binding Proteins; Humans; Hyperinsulinism; Hypoglycemia; Immediate-Early Proteins; Infant; Insulin; Islets of Langerhans; Membrane Proteins; Monomeric GTP-Binding Proteins; Mutation; Nifedipine; Octreotide; Pancreatectomy; Potassium Channels; Repressor Proteins; Saccharomyces cerevisiae Proteins | 1997 |
The diagnosis and management of hypertensive crises.
Topics: Antihypertensive Agents; Aortic Aneurysm; Aortic Dissection; Clonidine; Diazoxide; Enalaprilat; Female; Fenoldopam; Humans; Hypertension; Labetalol; Nicardipine; Nifedipine; Nitroprusside; Phentolamine; Pre-Eclampsia; Pregnancy; Propanolamines; Trimethaphan | 2000 |
[PHHI (persistent hyperinsulinemic hypoglycemia of infancy)].
Topics: Animals; ATP-Binding Cassette Transporters; Calcium Channel Blockers; Diagnosis, Differential; Diazoxide; Humans; Hyperinsulinism; Hypoglycemia; Infant; Infant, Newborn; Mutation; Nifedipine; Pancreatectomy; Potassium Channels; Potassium Channels, Inwardly Rectifying; Prognosis; Receptors, Drug; Sulfonylurea Receptors | 2002 |
Medications used in the treatment of hypoglycemia due to congenital hyperinsulinism of infancy (HI).
Topics: Congenital Hyperinsulinism; Diazoxide; Gastrointestinal Agents; Glucagon; Humans; Hypoglycemia; Infant; Nifedipine; Octreotide; Vasodilator Agents | 2004 |
1 trial(s) available for nifedipine and diazoxide
Article | Year |
---|---|
Oedema formation with the vasodilators nifedipine and diazoxide: direct local effect or sodium retention?
Topics: Adult; Cross-Over Studies; Diazoxide; Edema; Female; Humans; Male; Nifedipine; Reproducibility of Results; Sodium; Vasodilator Agents | 1996 |
45 other study(ies) available for nifedipine and diazoxide
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Inositol tetrakisphosphate isomers and elevation of cytosolic Ca2+ in vasopressin-stimulated insulin-secreting RINm5F cells.
Topics: Arginine Vasopressin; Calcium Channels; Cations, Divalent; Cell Line; Chromatography, Ion Exchange; Diazoxide; Diglycerides; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Insulin; Insulin Secretion; Isomerism; Membrane Potentials; Nickel; Nifedipine; Phosphorylation | 1992 |
Dual functional role of membrane depolarization/Ca2+ influx in rat pancreatic B-cell.
Topics: Adenosine Triphosphate; Animals; Biological Transport; Calcium; Calcium Channels; Cell Membrane Permeability; Cyclohexanones; Diazoxide; Exocytosis; Glucose; Islets of Langerhans; Male; Membrane Potentials; Nifedipine; Potassium; Potassium Channels; Rats; Rats, Inbred Strains; Signal Transduction | 1992 |
Intravenously administered labetalol for treatment of hypertension in children.
Topics: Adolescent; Child; Child, Preschool; Creatinine; Diazoxide; Heart Rate; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Nifedipine; Nitroprusside; Potassium; Time Factors | 1992 |
'Perforated patch recording' allows long-term monitoring of metabolite-induced electrical activity and voltage-dependent Ca2+ currents in pancreatic islet B cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Action Potentials; Animals; Azides; Calcium Channels; Diazoxide; Electric Conductivity; Glucose; Humans; Islets of Langerhans; Membrane Potentials; Nifedipine; Rats; Sodium Azide; Tolbutamide | 1989 |
Drugs for hypertensive emergencies.
Topics: Administration, Oral; Captopril; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Infusions, Parenteral; Labetalol; Nifedipine; Nitroprusside; Trimethaphan | 1985 |
[Clinical use of new antihypertensives].
Topics: Alkaloids; Antihypertensive Agents; Benzylisoquinolines; Captopril; Diazoxide; Diterpenes; Humans; Hypertension; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Prazosin | 1984 |
Effect of extra- and intracellular calcium blockers on histamine and antigen-induced bronchospasms in guinea pigs and rats.
Topics: Albuterol; Animals; Bronchial Spasm; Calcium Channel Blockers; Diazoxide; Gallic Acid; Guinea Pigs; Hemodynamics; Histamine; Immunization; Male; Nifedipine; Ovalbumin; Rats; Species Specificity; Verapamil | 1984 |
[The hypertensive crisis].
Topics: Acute Disease; Calcium Channel Blockers; Clonidine; Coronary Disease; Diazoxide; Dihydralazine; Diltiazem; Heart Failure; Humans; Hypertension; Nifedipine; Nitroprusside; Sympatholytics; Verapamil | 1984 |
Failure of nifedipine treatment in primary pulmonary hypertension.
Topics: Adult; Diazoxide; Female; Humans; Hypertension, Pulmonary; Nifedipine; Pyridines | 1982 |
Primary pulmonary hypertension: effects of nifedipine.
Topics: Adult; Diazoxide; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Nifedipine; Pulmonary Artery; Pyridines; Vascular Resistance | 1980 |
[Primary pulmonary arterial hypertension. Trial treatment with nifedipine, diazoxide and isoproterenol].
Topics: Diazoxide; Drug Therapy, Combination; Female; Humans; Hypertension, Pulmonary; Isoproterenol; Middle Aged; Nifedipine; Pyridines | 1980 |
Evidence that tolbutamide induces prolactin secretion by a mechanism which does not involve blocking ATP-sensitive potassium channels.
Topics: Adenosine Triphosphate; Animals; Diazoxide; Dopamine; Dose-Response Relationship, Drug; In Vitro Techniques; Kinetics; Male; Nifedipine; Pituitary Gland, Anterior; Potassium Channels; Prolactin; Rats; Rats, Sprague-Dawley; Tolbutamide | 1994 |
Activin A increases intracellular free calcium concentrations in rat pancreatic islets.
Topics: Activins; Animals; Calcium; Carbachol; Cyclic AMP; Diazoxide; Inhibins; Insulin; Insulin Secretion; Islets of Langerhans; Male; Nifedipine; Nitrendipine; Rats; Rats, Wistar; Verapamil | 1993 |
Effect of 4-aminopyridine and 3,4-diaminopyridine on guinea-pig isolated ileum.
Topics: 4-Aminopyridine; Acetylcholine; Amifampridine; Animals; Atropine; Calcium Channel Blockers; Diazoxide; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Female; Flunarizine; Guinea Pigs; Ileum; In Vitro Techniques; Lanthanum; Male; Muscle Contraction; Muscle, Smooth; Nifedipine; Parasympathetic Nervous System; Parasympatholytics; Potassium Channels; Vasodilator Agents; Verapamil | 1997 |
Microvascular permeability with sulfonylureas in normal and diabetic hamsters.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Capillary Permeability; Cricetinae; Dextrans; Diabetes Mellitus, Experimental; Diazoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorescein-5-isothiocyanate; Gliclazide; Glyburide; Histamine; Hypoglycemic Agents; Insulin; Macromolecular Substances; Male; Mesocricetus; Nifedipine; Potassium Channels; Reperfusion Injury; Streptozocin; Sulfonylurea Compounds | 1997 |
Cellular characterization of pituitary adenoma cell line (AtT20 cell) transfected with insulin, glucose transporter type 2 (GLUT2) and glucokinase genes: insulin secretion in response to physiological concentrations of glucose.
Topics: Adenoma; Calcium Channel Blockers; Corticotropin-Releasing Hormone; Diazoxide; Gene Expression; Glucokinase; Glucose; Glucose Transporter Type 2; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Monosaccharide Transport Proteins; Nifedipine; Pituitary Neoplasms; Potassium Chloride; Transfection; Tumor Cells, Cultured | 1998 |
Role of protein kinase C in mitochondrial KATP channel-mediated protection against Ca2+ overload injury in rat myocardium.
Topics: Adenosine Triphosphate; Alkaloids; Animals; Benzophenanthridines; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Coronary Circulation; Diazoxide; Enzyme Activation; Enzyme Inhibitors; Immunohistochemistry; Ischemic Preconditioning; Isoenzymes; L-Lactate Dehydrogenase; Male; Mitochondria; Myocardial Ischemia; Myocardium; Nifedipine; Phenanthridines; Potassium Channels; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Protein Kinase C-delta; Protein Kinase C-epsilon; Rats; Rats, Sprague-Dawley; Vasodilator Agents; Verapamil | 1999 |
Cytosolic Ca2+ oscillations by gastrin releasing peptide in single HIT-T15 cells.
Topics: Animals; Biological Transport; Calcium; Calcium Channel Blockers; Calcium Signaling; Cells, Cultured; Cytosol; Diazoxide; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Gastrin-Releasing Peptide; Glucose; Ion Channel Gating; Islets of Langerhans; Mice; Nifedipine; Protein Kinase C; Tetradecanoylphorbol Acetate; Thapsigargin | 1999 |
Threonine phosphorylations induced by RX-871024 and insulin secretagogues in betaTC6-F7 cells.
Topics: Amino Acid Sequence; Animals; Antihypertensive Agents; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Line; Cyclic AMP-Dependent Protein Kinases; Cytosol; Diazoxide; Exocytosis; Humans; Hypoglycemic Agents; Imidazoles; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Isomerism; Membrane Potentials; Membrane Proteins; Myosin Heavy Chains; Nifedipine; Phosphorylation; Potassium Chloride; Protein Kinase C; Subcellular Fractions; Threonine; Tolbutamide | 1999 |
Ca2+ influx does not trigger glucose-induced traffic of the insulin granules and alteration of their distribution.
Topics: Calcium; Calcium Signaling; Cell Line; Cytoplasm; Diazoxide; Dose-Response Relationship, Drug; Down-Regulation; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Myosin Light Chains; Nifedipine; Nitrendipine; Phosphorylation; Tetradecanoylphorbol Acetate; Time Factors | 2003 |
Growth hormone promotes Ca(2+)-induced Ca2+ release in insulin-secreting cells by ryanodine receptor tyrosine phosphorylation.
Topics: Animals; Calcium; Calcium Channel Blockers; Cells, Cultured; Diazoxide; Enzyme Inhibitors; Genistein; Growth Hormone; Insulin; Insulin Secretion; Islets of Langerhans; Membrane Potentials; Nifedipine; Phosphorylation; Potassium; Protein-Tyrosine Kinases; Rats; Ryanodine Receptor Calcium Release Channel; Thapsigargin; Tyrosine | 2004 |
Persistent hyperinsulinemic hypoglycemia presenting with a rare complication: West syndrome.
Topics: Adrenocorticotropic Hormone; Anticonvulsants; Congenital Hyperinsulinism; Diazoxide; Electroencephalography; Female; Humans; Infant; Myoclonus; Nifedipine; Phenobarbital; Spasms, Infantile; Treatment Outcome | 2004 |
Glucose-stimulated DNA synthesis through mammalian target of rapamycin (mTOR) is regulated by KATP channels: effects on cell cycle progression in rodent islets.
Topics: Animals; Blotting, Western; Calcium; Cell Cycle; Cell Division; Cell Proliferation; Cells, Cultured; Cytosol; Diazoxide; Dose-Response Relationship, Drug; Flow Cytometry; G2 Phase; Glucose; Glyburide; Islets of Langerhans; Male; Nifedipine; Potassium; Potassium Channels; Protein Kinases; Rats; Rats, Sprague-Dawley; S Phase; Sirolimus; Thymidine; TOR Serine-Threonine Kinases | 2006 |
Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
Topics: Animals; Calcium; Cell Line; Cells, Cultured; Diazoxide; Dose-Response Relationship, Drug; Female; Glucose; Humans; Insulin; Insulin-Secreting Cells; Ion Channel Gating; KATP Channels; Membrane Potentials; Nifedipine; Oocytes; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Propylamines; Rats; Tolbutamide; Xenopus laevis | 2007 |
In vitro evidences for glucosensing capacity and mechanisms in hypothalamus, hindbrain, and Brockmann bodies of rainbow trout.
Topics: Animals; Calcium Channel Blockers; Cytochalasin B; Deoxyglucose; Diazoxide; Glucokinase; Glucose; Glycogen; Glycolysis; Hexokinase; Hypothalamus; In Vitro Techniques; Kinetics; Mannose; Nifedipine; Oncorhynchus mykiss; Phosphorylation; Potassium Channels; Pyruvate Kinase; Rhombencephalon | 2007 |
Glucose-dependent changes in SNARE protein levels in pancreatic β-cells.
Topics: Animals; Blotting, Western; Diazoxide; Fluorescent Antibody Technique; Glucose; Immunohistochemistry; Insulin; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Nifedipine; Pancreatectomy; R-SNARE Proteins; Rats; Rats, Sprague-Dawley; SNARE Proteins; Synaptosomal-Associated Protein 25; Syntaxin 1; Vesicle-Associated Membrane Protein 2; Vesicle-Associated Membrane Protein 3; Vesicular Transport Proteins | 2011 |
Preconditioning with associated blocking of Ca2+ inflow alleviates hypoxia-induced damage to pancreatic β-cells.
Topics: AMP-Activated Protein Kinases; Animals; Calcium; Calcium Channel Blockers; Cell Hypoxia; Cells, Cultured; Diabetes Mellitus, Experimental; Diazoxide; Electron Transport Chain Complex Proteins; Humans; Hypoglycemic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; Insulin; Insulin-Secreting Cells; Male; Mice; Nifedipine; Oxygen; Phosphorylation; Potassium; Proinsulin; Rats; Streptozocin; Tolbutamide | 2013 |
A combination of nifedipine and octreotide treatment in an hyperinsulinemic hypoglycemic infant.
Topics: Child, Preschool; Codon, Nonsense; Congenital Hyperinsulinism; Diazoxide; Humans; Infant; Infant, Newborn; Male; Nifedipine; Octreotide; Pancreatectomy; Sulfonylurea Receptors | 2014 |
Inhibition of Calcium Influx Reduces Dysfunction and Apoptosis in Lipotoxic Pancreatic β-Cells via Regulation of Endoplasmic Reticulum Stress.
Topics: Animals; Apoptosis; Calcium Signaling; Cell Line, Tumor; Diabetes Mellitus, Type 2; Diazoxide; Endoplasmic Reticulum Stress; Insulin-Secreting Cells; Mice; Nifedipine; Palmitic Acid | 2015 |
A Case of Subclinical Hypothyroidism with Lingual and Right Pretracheal Ectopic Thyroid.
Topics: Blood Glucose; C-Peptide; Calcium Channel Blockers; Choristoma; Codon, Nonsense; Congenital Hyperinsulinism; Diazoxide; Diuretics; Drug Resistance; Female; Humans; Infant, Newborn; Insulin; Nifedipine; Octreotide; Pancreatectomy; Sulfonylurea Receptors; Thyroid Gland; Tongue Diseases | 2015 |
Nifedipine in Congenital Hyperinsulinism - A Case Report.
Topics: Blood Glucose; C-Peptide; Calcium Channel Blockers; Codon, Nonsense; Congenital Hyperinsulinism; Diazoxide; Diuretics; Drug Resistance; Female; Humans; Infant, Newborn; Insulin; Nifedipine; Octreotide; Pancreatectomy; Sulfonylurea Receptors | 2015 |
Impaired glucose-stimulated insulin secretion and reduced β-cell mass in pancreatic islets of hyperthyroid rats.
Topics: Animals; Calcium Channels, L-Type; Diazoxide; Glucose; Glucose Tolerance Test; Glyburide; Hyperthyroidism; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; KATP Channels; Male; Nifedipine; Rats; Rats, Sprague-Dawley; Thyroid Hormones; Thyroxine | 2016 |
Assessment of Nifedipine Therapy in Hyperinsulinemic Hypoglycemia due to Mutations in the ABCC8 Gene.
Topics: Calcium Channel Blockers; Child, Preschool; Cohort Studies; Congenital Hyperinsulinism; Diazoxide; Drug Therapy, Combination; Female; Gastrointestinal Agents; Glucagon; Humans; Infant; Male; Nifedipine; Octreotide; Prospective Studies; Starch; Sulfonylurea Receptors; Treatment Outcome | 2017 |